Confido Healthcare Group OÜ
Active Registry code 12874945
OÜ Tallinn Registered 6 Jul 2015
Confido Healthcare Group OÜ is a OÜ based in Tallinn, registry code 12874945, status: active. Main activity: Activities of holding companies. According to EMTA, turnover for Q3 2026 was €1 159 159 with 2 employees.
Turnover
1 159 159 €
↓ 5.3% vs Q2 2026
State taxes
161 912 €
↑ 2.7% vs Q2 2026
Labour taxes
79 428 €
↓ 15.1% vs Q2 2026
Employees
2
±0 vs Q2 2026
Q3 2026 · data from the Tax and Customs Board (EMTA)
Position in the industry
- Turnover · Q3 2026 1.2 mn €above 98% of companiesindustry median 13 555 € · companies in the industry: 547
- Labour taxes per employee 39 714 €above 98% of companiesindustry median 2 214 € · companies in the industry: 443
- Revenue · 2025 5.1 mn €above 98% of companiesindustry median 0 € · companies in the industry: 3 672
- Net profit margin · 2025 -61.8 %above 13% of companiesindustry median 34.4 % · companies in the industry: 770
Taxes and turnover
- Company
- Industry median
Industry: Financial service activities, except insurance and pension funding (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Financial service activities, except insurance and pension funding (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Quarter | Turnover, € | State taxes, € | Labour taxes, € | Employees |
|---|---|---|---|---|
| Q3 2026 | 1 159 159 | 161 912 | 79 428 | 2 |
| Q2 2026 | 1 224 055 | 157 694 | 93 590 | 2 |
| Q1 2026 | 1 193 728 | 123 999 | 84 039 | 2 |
| Q4 2025 | 1 146 520 | 135 684 | 85 710 | 2 |
| Q3 2025 | 1 138 872 | 133 314 | 85 548 | 2 |
| Q2 2025 | 1 159 519 | 164 159 | 85 491 | 2 |
| Q1 2025 | 1 162 064 | 134 700 | 104 589 | 2 |
| Q4 2024 | 1 139 240 | 152 201 | 90 211 | 2 |
| Q3 2024 | 1 057 912 | 139 021 | 92 854 | 2 |
| Q2 2024 | 1 073 688 | — | 90 047 | 3 |
| Q1 2024 | 1 082 125 | 105 286 | 108 771 | 2 |
| Q4 2023 | 1 016 808 | 87 255 | 77 752 | 2 |
| Q3 2023 | 1 006 106 | 85 450 | 73 676 | 2 |
| Q2 2023 | 1 071 003 | 90 146 | 75 872 | 2 |
| Q1 2023 | 1 128 825 | 30 075 | 49 422 | 1 |
| Q4 2022 | 1 095 444 | 34 882 | 49 211 | 1 |
| Q3 2022 | 953 492 | 27 641 | 48 687 | 1 |
| Q2 2022 | 1 229 549 | — | 32 279 | 1 |
| Q1 2022 | 1 012 649 | — | 25 957 | 1 |
Labour taxes per employee per month
13 238 €
Turnover per employee in the quarter
579 580 €
Q3 2026 · calculated from EMTA data
Financials by year
- Company
- Industry median
Industry: Financial service activities, except insurance and pension funding (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Financial service activities, except insurance and pension funding (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Financial service activities, except insurance and pension funding (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Financial service activities, except insurance and pension funding (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Year | Revenue, € | Net profit, € | Labour costs, € | Assets, € | Equity, € | Employees |
|---|---|---|---|---|---|---|
| 2026 | — | — | — | — | — | 5 |
| 2025 | 5 110 813 | -3 156 728 | 1 177 647 | 41 675 279 | 14 947 865 | 5 |
| 2023 | 3 470 336 | — | — | 35 471 197 | — | 5 |
| 2022 | 3 211 849 | — | — | 30 145 435 | — | 5 |
| 2021 | 2 337 690 | -1 037 624 | 255 663 | 16 205 326 | 5 440 206 | 5 |
| 2020 | 603 171 | -915 918 | 321 188 | 11 676 256 | 2 530 830 | 4 |
| 2019 | 278 599 | -824 801 | 154 442 | 4 987 629 | 3 827 279 | 0 |
| 2018 | — | — | — | — | — | 0 |
| 2017 | — | — | — | — | — | 0 |
| 2016 | — | — | — | — | — | 1 |
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.
Financial ratios for 2025
Net profit margin
-61.8 %
Net profit / revenue
Return on equity (ROE)
-21.1 %
Net profit / equity
Return on assets (ROA)
-7.6 %
Net profit / assets
Equity ratio
35.9 %
Equity / assets
Debt ratio
64.1 %
Liabilities / assets
Current ratio
0.97
Current assets / current liabilities
Revenue per employee
1 022 163 €
Revenue / average full-time employees
Labour cost per employee per month
19 627 €
Labour costs / employees / 12 months (incl. employer taxes)
Annual reports
| Year | Period | Filed | Report | Documents |
|---|---|---|---|---|
| 2024 | 1 Jan 2024 – 30 Apr 2025 | 31 Oct 2025 | Consolidated · audited | e-Äriregister |
| 2023 | 1 Jan 2023 – 31 Dec 2023 | 1 Jul 2024 | Consolidated · audited | e-Äriregister |
| 2022 | 1 Jan 2022 – 31 Dec 2022 | 30 Jun 2023 | Consolidated · audited | e-Äriregister |
| 2021 | 1 Jan 2021 – 31 Dec 2021 | 25 May 2022 | Consolidated · audited | e-Äriregister |
| 2020 | 1 Jan 2020 – 31 Dec 2020 | 30 Jun 2021 | Consolidated · audited | e-Äriregister |
| 2019 | 1 Jan 2019 – 31 Dec 2019 | 30 Jun 2020 | Consolidated · audited | e-Äriregister |
Commercial pledges
| No. | Amount | Pledgee | Period |
|---|---|---|---|
| 2 | 1 000 000 € | AS SEB Pank | 5 Dec 2022 – in force |
| 1 | 1 200 000 € | AS SEB Pank | 21 Feb 2022 – in force |
Board
- Piret Põldre-VahurBoard member · since 18 Oct 2021
- Edvard GarderBoard member · since 6 Apr 2023
- Nasdaq CSD SEKeeper of the share register · since 28 Sep 2017
Right of representation
Any member of the management board may represent the private limited company in all transactions.
Owners
- Omanikukonto: MM PHARMA OÜLegal person · 14080511 · 850 000 €
- Omanikukonto: MEDISPACE PARTNERS OÜLegal person · 16831890 · 150 000 €
Owner in
- 100%
- 100%
- 100%
- 100%
Beneficial owners
- Margus LinnamäeIndirect ownership · since 2 Aug 2023
Founders and other persons
- Kadi LambotFounder · 2 500 € · 6 Jul 2015
- Lauri KõrgveeChairman of the supervisory board · 6 Apr 2026
- Margus LinnamäeSupervisory board member · 31 Mar 2023
- Ahti KallikormSupervisory board member · 1 Jul 2024
Related companies
Activities (EMTAK)
- 64211Activities of holding companies Main
Rulings
All rulings (PDF)| Number, date | Title | Deadline | State | Document |
|---|---|---|---|---|
| Ä 50010950 / 35 13 Apr 2026 |
Amendment entry | In force 13 Apr 2026 |
||
| Ä 50010950 / 34 9 Apr 2026 |
Amendment entry | In force 9 Apr 2026 |
||
| Ä 50010950 / 33 31 Mar 2025 |
Amendment entry | In force 31 Mar 2025 |
||
| Ä 50010950 / 32 28 Dec 2023 |
Amendment entry | In force 28 Dec 2023 |
||
| Ä 50010950 / 31 13 Nov 2023 |
Amendment entry | In force 13 Nov 2023 |
||
| Ä 50010950 / 30 2 Aug 2023 |
Amendment entry | In force 2 Aug 2023 |
||
| Ä 50010950 / 29 14 Apr 2023 |
Amendment entry | In force 14 Apr 2023 |
||
| Ä 50010950 / 28 6 Apr 2023 |
Amendment entry | In force 6 Apr 2023 |
||
| Ä 50010950 / 27 5 Apr 2023 |
Amendment entry | In force 5 Apr 2023 |
||
| Ä 50010950 / 26 20 Mar 2023 |
Amendment entry | In force 20 Mar 2023 |
||
| Ä 50010950 / 25 21 Dec 2022 |
Amendment entry | In force 21 Dec 2022 |
||
| K 50010950 / 24 5 Dec 2022 |
Commercial pledge entered | In force 5 Dec 2022 |
||
| Ä 50010950 / 23 26 May 2022 |
Amendment entry | In force 26 May 2022 |
||
| K 50010950 / 22 21 Feb 2022 |
Commercial pledge entered | In force 21 Feb 2022 |
||
| Ä 50010950 / 21 18 Feb 2022 |
Amendment entry | In force 18 Feb 2022 |
||
| Ä 50010950 / M4 17 Feb 2022 |
Ruling to eliminate deficiencies | 3 Mar 2022 | Deficiencies eliminated 20 Feb 2022 |
|
| Ä 50010950 / 20 17 Feb 2022 |
Entry refused: deficiencies not eliminated | In force 5 Mar 2022 |
||
| Ä 50010950 / M3 2 Feb 2022 |
Ruling to eliminate deficiencies | 16 Feb 2022 | In force 2 Feb 2022 |
|
| Ä 50010950 / 19 18 Oct 2021 |
Amendment entry | In force 18 Oct 2021 |
||
| Ä 50010950 / M2 7 Sep 2021 |
Ruling to eliminate deficiencies | 21 Sep 2021 | In force 7 Sep 2021 |
|
| Ä 50010950 / 18 30 Mar 2021 |
Amendment entry | In force 30 Mar 2021 |
||
| Ä 50010950 / 17 11 Nov 2020 |
Amendment under Commercial Code § 525 (2) | In force 11 Nov 2020 |
||
| Ä 50010950 / 16 23 Oct 2020 |
Amendment entry | In force 23 Oct 2020 |
||
| Ä 50010950 / 15 6 Oct 2020 |
Amendment entry | In force 6 Oct 2020 |
||
| Ä 50010950 / 14 30 Jun 2020 |
Amendment entry | In force 30 Jun 2020 |
||
| Ä 50010950 / 13 30 Apr 2020 |
Second (constitutive) merger entry | In force 30 Apr 2020 |
||
| Ä 50010950 / 12 7 Apr 2020 |
Amendment entry | In force 7 Apr 2020 |
||
| Ä 50010950 / 11 11 Nov 2019 |
Amendment entry | In force 11 Nov 2019 |
||
| Ä 50010950 / 10 19 Sep 2019 |
Amendment entry | In force 19 Sep 2019 |
||
| Ä 50010950 / 9 3 May 2019 |
Amendment entry | In force 3 May 2019 |
||
| Ä 50010950 / 8 10 Dec 2018 |
Amendment entry | In force 10 Dec 2018 |
||
| Ä 50010950 / M1 6 Dec 2018 |
Ruling to eliminate deficiencies | 5 Jan 2019 | Deficiencies eliminated 10 Dec 2018 |
|
| Ä 50010950 / 7 14 Nov 2018 |
Amendment entry | In force 14 Nov 2018 |
||
| Ä 50010950 / 6 19 Jan 2018 |
Amendment entry | In force 19 Jan 2018 |
||
| Ä 50010950 / 5 10 Dec 2017 |
Amendment entry | In force 10 Dec 2017 |
||
| Ä 50010950 / 4 28 Sep 2017 |
Amendment entry | In force 28 Sep 2017 |
||
| Ä 50010950 / 3 17 Jul 2015 |
Amendment entry | In force 17 Jul 2015 |
||
| Ä 50010950 / 2 13 Jul 2015 |
Amendment entry | In force 13 Jul 2015 |
||
| Ä 50010950 6 Jul 2015 |
First entry | In force 6 Jul 2015 |
Sources: e-Äriregister and EMTA. Data updated 2 Nov 2026. Open at the source ↗ · Report an error in the data